Ventyx stock climbs 7% on signing a $27 million strategic investment agreement with Sanofi in exchange for granting exclusive ...
What Factors Have Led to Ventyx Biosciences Inc (VTYX) Stock Trading -93.48% Below Its 52-Week High?
On Thursday, Ventyx Biosciences Inc (VTYX) stock saw a decline, ending the day at $2.36 which represents a decrease of $-0.03 or -1.26% from the prior close of $2.39. The stock opened at $2.43 and ...
Ventyx Biosciences Inc (VTYX) stock saw a modest uptick, ending the day at $2.46 which represents a slight increase of $0.16 or 6.96% from the prior close of $2.3. The stock opened at $2.66 and ...
Shares of Ventyx Biosciences VTYX gained 7% on Monday after the company announced that it has entered into a $27 million strategic investment agreement with Sanofi SNY. Per the terms of the deal ...
Oppenheimer analyst Jeff Jones maintained a Buy rating on Ventyx Biosciences (VTYX – Research Report) today and set a price target of ...
In a report released yesterday, Sam Slutsky from LifeSci Capital maintained a Buy rating on Ventyx Biosciences (VTYX – Research Report).
Ventyx (VTYX) stock jumped 8% on news that Sanofi (SNY) has made a $27M strategic investment in the company at an ...
Sanofi invests $27 million in Ventyx Biosciences at $3.8243 per share. The investment will fund VTX3232 trials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback